| Name | Title | Contact Details |
|---|
Lexicon Pharmaceuticals, Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Spring, TX. To find more information about Lexicon Pharmaceuticals, Inc, please visit www.lexpharma.com
We`re FinThrive and we believe revenue management technology will drive the future of healthcare. We pave the way for a healthcare system that ensures every transaction and patient experience is addressed holistically. FinThrive creates integrated technology that adapts with healthcare professionals – freeing them from complexity and inefficiency so they can focus on doing their best work. Our end-to-end revenue management platform provides financial teams and stakeholders with greater reliability and control to deliver better outcomes for everyone. With our vision, technology, experience and scale, we`re advancing the healthcare economy.
Washington State Hospital Association is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Vertava Health Mississippi is an addiction treatment center that provides evidence-based, multi-level care for individuals with substance use and co-occurring mental health disorders.
Fresenius Kabi is a global health care company that specializes in lifesaving medicines and medical technologies for infusion, transfusion and clinical nutrition. Our expansive portfolio of products and global network of science and manufacturing centers provide essential support for the care of critical and chronically ill patients. We are part of Fresenius SE, a health care group with more than 100 years of experience in pharmaceuticals, medical devices and life sciences. Our employees – more than 35,000 worldwide – develop and deliver injectable pharmaceuticals and infusion systems; blood collection, transfusion and cell technologies; and essential nutrients for parenteral nutrition. We have special expertise in medicines for oncology, infection, anesthesia, analgesia and critical care. Our products are used in all sites of care – from hospitals and clinics to blood and plasma centers, and increasingly in patients’ homes. In biosimilars, we are developing products with a focus on oncology and autoimmune diseases.